Clinical trial
TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer
NCT00137878 · GenVec, Industry · Completed
Key facts
| NCT number | NCT00137878 |
|---|---|
| Title | TNFerade™ Plus Chemo/Radiation/Surgery for Rectal Cancer |
| Official title | A Phase II Randomized Trial Comparing TNFerade™ Biologic With Capecitabine and Radiation Therapy Followed by Surgical Resection Versus Capecitabine and Radiation Therapy Followed by Surgical Resection for the Treatment of Rectal Cancer |
| Lead sponsor | GenVec, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rectal Cancer |
| Intervention type | Drug |
| Interventions | TNFerade™ |
| First posted | Aug 30, 2005 |
| Last update posted | Feb 23, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: